+ 1.24
+ 0.41%
+ 2.49
+ 0.83%
+ 3.11
+ 0.85%

Can Cannabis Ease Coronavirus Symptoms? Toronto Firm Applies For Clinical Trial

March 26, 2020 3:40 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Medical cannabis company Cannalogue decided to step into the fight against the coronavirus pandemic by researching the effects of medical cannabis on the virus.

The Canadian online medical cannabis marketplace has applied to Health Canada for approval to organize a clinical trial of medical cannabis in COVID-19.

If it receives Health Canada’s authorization, Cannalogue said it will enroll patients in the study to research if medical cannabis can help ease the symptoms caused by COVID-19 or any mutant strains of coronavirus.

Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.

"The need is too great and we have to act now,” Cannalogue CEO Mohan Cooray said in a statement. “We are not suggesting with the current knowledge of medical cannabis that it is a prevention, treatment or cure for COVID-19 or coronaviruses. However, plant cannabinoids have naturally occurring immunomodulatory properties that absolutely require expedited investigation given the current global COVID-19 pandemic.”

The Toronto-based company said the medical ingredients found in cannabis have the potential of enhancing the immune system to minimize the symptoms of COVID-19.

“Cannabinoid receptors are naturally found on immune cells in the body. If stimulated prior to an infection, it may dampen the inflammatory response that follows, which is a key factor in the severity of symptoms observed in patients,” Cooray said. “If we can’t flatten the curve, then we need to focus on reducing the number of deaths.”

Versión en Español en El Planteo, via Benzinga: ¿Puede la Marihuana Aliviar los Síntomas de Coronavirus?

Lee Benzinga Cannabis en Español: 3 Maneras de Compartir Cannabis sin Transmitir el Coronavirus

Related Articles

Aleafia Health Presents Debuts High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. (TSX: AH) (OTCQX: ALEAF) is launching high potency CBD 50 oils. The cannabis company crafted SymblTM High CBD 50 and EmblemTM CBD 50 to meet the needs of both adult-use consumers and medical patients, respectively. read more

Merry Marijuana: 8 Ganja Gift Ideas For Loved Ones Who Wish To Enjoy A Holiday High

It may not feel like it this year, but yes — the holidays are upon us. Indeed, shopping for gifts will be different since the coronavirus pandemic will likely keep many of us from going to stores.  read more

Cannabis Movers & Shakers: Pure Harvest, Allied, Bluma, Vitalis, Aurora, MedMen, Flora Growth

Here is a summary of the latest company shakeups within the cannabis industry. read more

New Cannabis Products: A Hemp Spirit, A New Jane West Collab, CBD From Citrus Peels

As the cannabis market expands, it's hard to keep track of the many products that launch every week. Benzinga put together a short list of some of the most interesting new cannabis products. read more

PreMarket Prep Stock Of The Day: GW Pharmaceuticals

Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session. read more